Donnez J, Gillerot S, Bourgonjon D, Clerckx F, Nisolle M
Department of Gynecology, University of Louvain, Brussels, Belgium.
Fertil Steril. 1990 Dec;54(6):999-1003. doi: 10.1016/s0015-0282(16)53994-6.
The preoperative use of a potent, subcutaneously injected gonadotropin-releasing hormone agonist (GnRH-a) was evaluated in a series of 60 women with large submucosal fibroids. Myomectomy by hysteroscopy and Nd:YAG laser was easily performed. In 12 cases, the largest portion of the myoma was not inside the uterine cavity and myomectomy was carried by a two-step hysteroscopy. In women who wished to become pregnant, a pregnancy rate of 66% was achieved. Advantages of preoperative use of a GnRH-a are (1) the significant decrease of the fibroid size, (2) a lower fluid absorption, and (3) the restoration of a normal hemoglobin concentration.
对60例患有大型黏膜下肌瘤的女性进行了皮下注射强效促性腺激素释放激素激动剂(GnRH-a)的术前应用评估。通过宫腔镜和Nd:YAG激光进行肌瘤切除术很容易实施。在12例病例中,肌瘤的最大部分不在子宫腔内,肌瘤切除术通过两步宫腔镜手术进行。在希望怀孕的女性中,妊娠率达到了66%。术前使用GnRH-a的优点包括:(1)肌瘤大小显著减小;(2)液体吸收减少;(3)血红蛋白浓度恢复正常。